Andrew Cox, PhD, is Co-Founder & CEO of ImmunoScope. He received his PhD in molecular and computational biology from UT Southwestern Medical Center, where his dissertation focused applied computational biology to augment the hematopathology diagnosis workflow. He has authored peer-reviewed studies in digital pathology, multiparameter flow cytometry, and cytogenetics, and is a UCSF’s Catalyst Award Internship alumni and Blackstone Launchpad Fellow. An awarded innovator and leader, some of his proudest entrepreneurial accomplishments to date involve helping ImmunoScope secure critical non-dilutive funding by winning pitch competitions, including the inaugural Texas Nucleate Activator and UT Southwestern Innovation Days. He enthuleads ImmunoScope’s mission to turn immune complexity into clear, clinically useful insights.